A delegation from Crown Bioscience and MBL International Corporation visited Lingang Innovation Center to discuss cooperation-SHLINGANGIC

On October 21st, Henry Li, Chief Scientist of Crown Bioscience Co., Ltd., Shirley Huang, Senior Vice President of Human Resources, and Yuxiong Guo, Executive Director and President of MBL International Corporation in China, visited Lingang Innovation Center. Mr. Lin Qu, General Manager of Lingang Innovation Center, and Mr.Hongfei Zhang, General Manager of Lingang Innovation Center Overseas Affairs Department, received the reception, and the two sides conducted in-depth exchanges on the possibility of Crown Bioscience’s development in Lingang.

Mr. Henry Li said that Crown Bioscience was established in 2006 and is headquartered in San Diego, California. It has operating entities in the United States, the United Kingdom, the Netherlands, and China. It is a cutting-edge drug discovery and development company that provides oncology, inflammation and self-services related to immune diseases. Since 70% of Crown Bioscience’s customers are overseas, and R&D personnel need frequent domestic and foreign exchanges, Mr. Li hopes to understand Lingang’s policies in connection with overseas logistics and also hopes to understand Lingang’s taxation, financial and other specific policies.

A delegation from Crown Bioscience and MBL International Corporation visited Lingang Innovation Center to discuss cooperation-SHLINGANGIC

Mr. Yuxiong Guo said that MBL International Corporation is a sister company of Crown Bioscience, and both belong to JSR Life Sciences. It is an internationally renowned professional company producing clinical diagnostic and research reagents. The company is headquartered in Japan and has branches in the United States and China. It has settled in Beijing, Hangzhou, and Shenzhen in China, but has no presence in Shanghai. However, most of the product sales in China are in Shanghai. Mr. Guo hopes to learn more about Lingang’s policies and the possibility of developing in Lingang.

General Manager Lin Qu said that Lingang is the most open pilot free trade zone in China, with relatively free movement of talent and finance, and convenient access to technology. Lingang has preferential tax policies for enterprises and executives that meet the requirements. Lingang provides convenient services for Chinese visas and other matters, which are very beneficial to Crown Bioscience and MBL. Lingang Innovation Center is a national technology business incubator, which can help the development of the two companies in Lingang, and when they encounter policy problems in the process of enterprise development, they can work with the Lingang Management Committee in a timely manner. In addition, Lingang Innovation Center is also building sub-centers in the Yangtze River Delta to help entrepreneurs and companies expand abroad.

The two parties conducted in-depth exchanges on policy details. At the end of the meeting, Ms. Shirley Huang expressed her interest in the development of Lingang and hoped to maintain active contact and discuss cooperation matters together.